Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 6/20 | 0.56 |
| ▸ | CCND1 | P24385 | 6/20 | 0.56 |
| ▸ | CCND3 | P30281 | 5/20 | 0.56 |
| ▸ | CDK6 | Q00534 | 5/20 | 0.56 |
| ▸ | CCNA2 | P20248 | 3/20 | 0.56 |
| ▸ | CDK2 | P24941 | 3/20 | 0.56 |
| ▸ | CCNA1 | P78396 | 3/20 | 0.56 |
| ▸ | CDK1 | P06493 | 3/20 | 0.55 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.55 |
| ▸ | NMT1 | P30419 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL112651 | 0.83 | CDK4 (0.74) | CDK4CCND1CCND3CDK6CCNA2 | |
| SCHEMBL114117 | 0.83 | CDK4 (0.78) | CDK4CCND1CCND3CDK6CCNA2 | |
| SCHEMBL111464 | 0.82 | CDK4 (0.53) | CDK4CCND1CCND3CDK6CCNA2 | |
| SCHEMBL112177 | 0.82 | CDK4 (0.75) | CDK4CCND1CCND3CDK6CCNA2 | |
| SCHEMBL110190 | 0.82 | CDK4 (0.57) | CDK4CCND1CCND3CDK6CCNA2 | |
| SCHEMBL112120 | 0.81 | CDK4 (0.55) | CDK4CCND1CCND3CDK6CDK1 | |
| SCHEMBL2142259 | 0.80 | CDK4 (0.59) | CDK4CCND1CCND3CDK6CCNA2 | |
| SCHEMBL28799660 | 0.74 | CDK4 (0.62) | CDK4CCND1CCND3CDK6CCNA2 | |
| SCHEMBL110043 | 0.74 | CDK4 (0.60) | CDK4CCND1CCND3CDK6CCNA2 | |
| SCHEMBL10268248 | 0.74 | CDK4 (0.62) | CDK4CCND1CCND3CDK6CCNA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2424843-A1 | IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES | Novartis AG (CH) | 2012-03-07 | — | — | EP | claimed |